Skip to content
TrackPodcasts
newsApr 30, 20261:19

GLP-1 Drugs: Weight Loss & Rebound Risks

About this episode

GLP-1 drugs like Ozempic and Wegovy, used for weight loss, may lead to rapid weight regain within 18 months of stopping. A study in the British Medical Journal found users regain weight four times faster than those who diet and exercise. These drugs curb cravings and slow digestion, but stopping them can undo heart and metabolic benefits. A University of Cambridge study supports this, showing 60% weight regain within a year off the drugs. Experts advise pairing medication with diet and exercise for long-term weight management.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/1e37339015aaa947

Get every episode summarized

Each time UK News Today | 2 Min News | The Daily News Now! publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Transcript ready

19 searchable segments. Every word is indexed and playable.

GLP-1 Drugs: Weight Loss & Rebound Risks

UK News Today | 2 Min News | The Daily News Now!

0:00
1:19

Full transcript

UK News Today | 2 Min News | The Daily News Now!GLP-1 Drugs: Weight Loss & Rebound Risks. Machine-transcribed; use the interactive transcript above to jump the player to any line.

On April 30th, folks using GLP-1 drugs like Ozympic and WagoV for weight loss need to know this. Research shows most regain all that weight within. About 18 months of quitting, a big analysis found they packet back on four times faster than folks who slim down through diet and exercise alone. These meds curb cravings, slow digestion, and keep you full longer, mimicking hormones your body makes. The British Medical Journal study crunched data from 37 trials with 9,000 people, warning that stopping leads to quick regain and, wipes out heart and metabolic gains. Obesity hits nearly 2 billion adults worldwide, hiking risks for disease and early death. Short-term use reverses those winds fast, with folks gaining about .8 kilograms a month, hitting baseline in 1.5 years. A fresh university of Cambridge study backs it up, showing 60% weight regain by one year off the drugs. They figure some habits like smaller portions might stick, helping a bit, but docks urge

pairing meds with diet tweaks and workouts to fight rebound. Pharma giant Novo Nordisk agrees obesity is chronic, like diabetes, so ongoing treatment might be key to hold those health boosts. Bottom line, think long game and holistic plans before jumping on or off these shots.

More episodes

More from UK News Today | 2 Min News | The Daily News Now!

View all episodes →